- Home
- AMRX vs SFBS Comparison
AMRX vs SFBS Comparison
Compare AMRX & SFBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMRX
- SFBS
- Stock Information
- Founded
- AMRX 2002
- SFBS 2005
- Country
- AMRX United States
- SFBS United States
- Employees
- AMRX N/A
- SFBS 659
- Industry
- AMRX Biotechnology: Pharmaceutical Preparations
- SFBS Major Banks
- Sector
- AMRX Health Care
- SFBS Finance
- Exchange
- AMRX Nasdaq
- SFBS Nasdaq
- Market Cap
- AMRX 3.3B
- SFBS 3.9B
- IPO Year
- AMRX N/A
- SFBS 2014
- Fundamental
- Price
- AMRX $10.21
- SFBS $68.60
- Analyst Decision
- AMRX Buy
- SFBS Hold
- Analyst Count
- AMRX 3
- SFBS 1
- Target Price
- AMRX $12.00
- SFBS $80.00
- AVG Volume (30 Days)
- AMRX 1.4M
- SFBS 237.6K
- Earning Date
- AMRX 10-30-2025
- SFBS 10-20-2025
- Dividend Yield
- AMRX N/A
- SFBS 1.88%
- EPS Growth
- AMRX N/A
- SFBS 24.85
- EPS
- AMRX 0.01
- SFBS 4.67
- Revenue
- AMRX $2,852,914,000.00
- SFBS $497,701,000.00
- Revenue This Year
- AMRX $9.70
- SFBS $24.82
- Revenue Next Year
- AMRX $6.53
- SFBS $16.91
- P/E Ratio
- AMRX $970.62
- SFBS $14.75
- Revenue Growth
- AMRX 9.81
- SFBS 16.10
- 52 Week Low
- AMRX $6.69
- SFBS $66.48
- 52 Week High
- AMRX $10.68
- SFBS $101.37
- Technical
- Relative Strength Index (RSI)
- AMRX 52.54
- SFBS 26.34
- Support Level
- AMRX $10.13
- SFBS $69.84
- Resistance Level
- AMRX $10.62
- SFBS $71.77
- Average True Range (ATR)
- AMRX 0.28
- SFBS 2.44
- MACD
- AMRX -0.01
- SFBS -0.59
- Stochastic Oscillator
- AMRX 57.02
- SFBS 1.67
About AMRX Amneal Pharmaceuticals Inc.
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.
About SFBS ServisFirst Bancshares Inc.
Servisfirst Bancshares Inc is a bank holding company whose business is conducted by its wholly owned subsidiary, ServisFirst Bank. Through the bank, it offers various banking services to individual and corporate customers in Birmingham, Florida, Georgia, North Carolina, South Carolina, Tennessee, and Virginia. Its various products and service offerings include commercial, consumer, and other loans; accepting deposits; providing electronic banking services, such as online and mobile banking, including remote deposit capture; delivering treasury and cash management services; and providing banking services to other financial institutions. The company operates as a single reportable segment, with a majority of its revenue being derived from the business of banking.